Meto's clinical breakdown of how semaglutide and tirzepatide are reshaping metabolic medicine covers SURMOUNT-5 head-to-head data in full
This test is not part of the routine panel but is ordered selectively
Kleinman HK, Sosne G
In contrast to tirzepatide, maridebart cafraglutide is a long-acting peptideantibody conjugate that combines GLP-1 agonism with GIP antagonism
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Rizvi S, Raza ST, Ahmed F, Ahmad A, Abbas S, Mahdi F
| Your Weekly Dose | Best Vial Size | Why | |-----------------|---------------|-----| | 1-2mg (titration) | 10mg or 12mg | Less waste, used within 28 days | | 4mg (low therapeutic) | 24mg or 30mg | 6-7 weeks supply, best value | | 8mg (mid therapeutic) | 30mg or 50mg | 3-4 weeks supply at good value | | 12mg (maximum) | 50mg or 60mg | 4-5 weeks supply, lowest cost/mg | *Medical disclaimer: Retatrutide is investigational and not FDA approved